BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2006
View Archived Issues
CombinatoRx and CFFT collaborate on synergistic drug combinations for CF
Read More
Rib-X and Wakunaga Pharmaceutical sign license agreement for WQ-3034
Read More
Phase III safety study of AIR insulin completes enrollment
Read More
Novartis launches ENACT program for expanded access to nilotinib
Read More
Novartis licenses rights to Albuferon
Read More
New phase III study of darusentan in resistant hypertension
Read More
Phase II study for PXD-101 in AML
Read More
Phase III results of lisdexamfetamine in ADHD presented
Read More
Stimulant medications most effective in treating attention deficit hyperactivity disorder
Read More
PQ-401: targeting IGF-IR to reduce breast cancer cell growth
Read More
AZ-001 studied in phase IIb trial for migraine
Read More
Recent patents describe new treatments for endocrine-related disorders
Read More
Biovest files to expand phase III study of BiovaxID to Russia and Ukraine
Read More
Clinical Data targeting 2006 launch of genetic test for warfarin response
Read More
Orphan drug designation for Xechem's 5-HMF in sickle cell disease
Read More
Development plans for three dosage forms of methylnaltrexone
Read More
Abilify launched in Japan
Read More
Agents for gastrointestinal disorders claimed in recent patents
Read More
Amorcyte begins phase I cell therapy for cardiovascular disease
Read More
FDA response to pre-IND for FV-100 for shingles
Read More
Novel treatment for HIV infection reported by Panacos
Read More
Japanese launch for Detrusitol for overactive bladder
Read More
Merck & Co. brings forward anticipated NDA filing for MK-0431A
Read More
Competact for type 2 diabetes recommended for approval in Europe
Read More
Betaferon approved in Europe as first-line treatment for earliest stages of MS
Read More
Humira approved in Europe for ankylosing spondylitis
Read More
Multiple kinase inhibitor shows oral activity in NSCLC
Read More
Promising preliminary phase I data for human anti-EGFR MAb
Read More
Positive phase II results for SP-1049C in esophageal adenocarcinoma; phase III planned
Read More
Multiple-dose study of BMS-582664 in patients with metastatic refractory solid tumors
Read More
Favorable clinical and preclinical data presented on pan-Bcl-2 inhibitor GX15-070
Read More
First clinical results reported for Plk1 inhibitor BI-2536
Read More
Novel ceramide analogue shows preclinical efficacy against head and neck tumors with gemcitabine
Read More